Caplight Directory>Companies>HeliXon-preview>Huashen-zhiyao


HeliXon

HeliXon

Private
Beijing, BeijingHealthcare & Life Scienceshttps://www.helixon.com

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$74.8M

Momentum Score

25 /100

Company Overview

Huashen Zhiyao is a biotechnology company that offers an artificial intelligence platform for scientific computing aimed at enhancing medical research and drug development efficiency.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoveryprotein therapeuticsAI protein designantibody discoverydrug discovery platformin silico drug discoveryAIDDclosed-loop discoverydeep learninggenerative biologybiotech AImacromolecular drugshigh-throughput biologycomputational biologyprotein interface optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HeliXon Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HeliXon Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
AngelOct 1, 2021
View all Funding Rounds

HeliXon Investors

Notable investors and investment history

InvestorRounds
Hillhouse InvestmentSeries A
Neumann AdvisorsSeries A
Neumann CapitalSeries A
GL VenturesSeries A, Angel
5Y CapitalSeries A
Gaorong Partners FundSeries A
GL VenturesSeries A
View all Investors

HeliXon Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HeliXon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HeliXon's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Employee Range11
Year Founded2009
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.